Article
NudCL2 suppresses pancreatic cancer progression by inhibiting SLC7A11-mediated EMT and metastasis
1 Sept 2025
Abstract excerpt
Pancreatic cancer (PC) is a highly aggressive malignancy with limited therapeutic options and poor prognosis. NudC-like protein 2 (NudCL2), a molecular cochaperone of HSP90, has been implicated in various cellular processes; however, its role in pancreatic cancer remains poorly understood. In this study, we report that NudCL2 expression is significantly downregulated in PC tissues and is correlated with poor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
